Skip to content

Measurement of Changes in GABA Concentration in the Human Brain Following Rosmarinic Acid Administration Using Magnetic Resonance Spectroscopy

Measurement of Changes in GABA Concentration in the Human Brain Following Rosmarinic Acid Administration Using Magnetic Resonance Spectroscopy - Measurement of Changes in GABA Concentration in the Human Brain Following Rosmarinic Acid Administration Using Magnetic Resonance Spectroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054669
Enrollment
10
Registered
2024-06-15
Start date
2024-06-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Administration of a rosmarinic acid-containing supplement and MRI imaging

Sponsors

Department of Neuropsychiatry, Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Healthy individual 2.Having the capacity to consent (as it is necessary for the research subjects to have a full understanding of the study) 3.Being 18 years old or older, and under 45 years old

Exclusion criteria

Exclusion criteria: 1.Diagnosed with a mental disorder according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR) 2.Pregnant or breastfeeding women 3.History of physical dysfunction such as liver, kidney, or heart issues 4.Allergies to herbs, supplements, or polyphenols 5.Smokers 6.Currently taking medication 7.Having an implanted metal device such as a pacemaker (for safety reasons) 8.Head, neck, or body size not suitable for the MRI scanner (for safety reasons) 9.Having a tattoo larger than a one-point size, including tattoos and permanent makeup (for safety reasons) 10.Severe claustrophobia (for safety reasons)

Design outcomes

Primary

MeasureTime frame
Changes in brain GABA concentration before and after administration of a rosmarinic acid-containing supplement, measured by MRS imaging.

Countries

Japan

Contacts

Public ContactHiroyuki Uchida

Keio University School of Medicine Department of Neuropsychiatry

hiroyuki_uchida@keio.jp03-5363-3971

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026